Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

The prescribing of antiviral drugs for US children and adolescents receiving treatment for influenza was less than 60% in the ...

A 50-year-old patient consulted doctors at a private hospital in Abu Dhabi with a persistent dry cough and low-grade fever ...

An advancement in diabetes treatment has been achieved by Professor Hyun-Wook Kang and his team from the Department of ...

The resubmitted sBLA will include results from Study C, which evaluated biologic-naive patients with uncontrolled CSU on antihistamines.

The dry powder inhaler market is projected to be worth USD 20.83 billion in 2024. The market is likely to reach USD 29.95 ...

The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

Doctors recommend avoiding NSAIDs after a flu vaccination because these can dampen the immune response by slashing the ...

Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm ...

Against the backdrop of high medical costs and an imbalance of access to care, is there reason to be optimistic about the ...

Researchers discovered an unexpected link between zinc deficiency, the pro-inflammatory cytokine interleukin-13 (IL-13), and Acinetobacter baumannii lung infection and demonstrated that blocking IL-13 ...

A rehabilitation centre for women in Shediac, N.B. is trying to expand its services, but it's getting pushback from residents ...